High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Baral, Pankaj ^a,b   Neupane, Sanjiv ^a   Marasini, Bishnu ^a   Ghimire, Kashi ^a   Lekhak, Binod ^a   Shrestha, Basudha ^c  

^a TRIBHUVAN UNIVERSITY   (Nepal)

^b Mahidol University ^*  (Thailand)

^c Kathmandu Model Hospital   (Nepal)

Author keywords

Multidrug resistance; Plasmid; Urinary tract infection

Indexed keywords

BACTERIA (MICROORGANISMS); CITROBACTER; ESCHERICHIA COLI;

EID: 84855870124     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-38     Document Type: Article

References (37)

1. Treatment of bacterial urinary tract infections: presence and future. Wagenlehner FM, Naber KG, Eur Urol 2006 49 2 235 244 10.1016/j.eururo.2005.12. 017 16413668 (Pubitemid 43197859)
2. Addressing antibiotic resistance. Gupta K, Am J Med 2002 113 Suppl 1A 29 S34
3. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Giamarellou H, Int J Antimicrob Agents 2010 36 Suppl 2 50 S54 21129924
4. High prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Nepal. Hammer DA, Dongol S, Anderson TP, Wong JS, Werno AM, Murdoch DR, Int J Antimicrob Agents 2007 30 5 471 472 10.1016/j.ijantimicag. 2007.07.004 17851048 (Pubitemid 47498966)
5. Urinary tract pathogens and resistance pattern. Chakupurakal R, Ahmed M, Sobithadevi DN, Chinnappan S, Reynolds T, J Clin Pathol 2010 63 7 652 654 10.1136/jcp.2009.074617 20501451
6. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Karlowsky JA, Lagace-Wiens PR, Simner PJ, DeCorby MR, Adam HJ, Walkty A, Hoban DJ, Zhanel GG, Antimicrob Agents Chemother 2011 55 7 3169 3175 10.1128/AAC.00066-11 21537027
7. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A, Int J Infect Dis 2009 13 2 140 144 10.1016/j.ijid.2008. 04.014 18703368
8. Horizontal transfer of antimicrobial resistance by extended-spectrum beta lactamase-producing Enterobacteriaceae. Vaidya VK, J Lab Physicians 2011 3 1 37 42 10.4103/0974-2727.78563 21701662
9. Harley JP, Prescott LM, Laboratory exercises in microbiology Mc-Graw-Hill Publishers 5 2002 37 237
10. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute, sixteenth informational supplement document M100-S16 Wayne, PA: Clinical and Laboratory Standards Institute 2006
11. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA, Antimicrob Agents Chemother 2001 45 5 1402 1406 10.1128/AAC.45.5.1402-1406.2001 11302802 (Pubitemid 32374109)
12. Prevalence and characterization of extended-spectrum beta-lactamase- and AmpC beta-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Simner PJ, Zhanel GG, Pitout J, Tailor F, McCracken M, Mulvey MR, Lagace-Wiens PR, Adam HJ, Hoban DJ, Diagn Microbiol Infect Dis 2011 69 3 326 334 10.1016/j.diagmicrobio.2010.10.029 21353961
13. Clinical and Laboratory Standards Institute, Methods for dilution antimicrobial susceptibility tests for bacteria that grows aerobically Wayne, PA: Clinical and Laboratory Standards Institute Seventh 2006
14. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute, Eighteenth informational supplement document M100-S18 Wayne, PA: Clinical and Laboratory Standards Institute 2008
15. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian urinary isolate study group. Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, Hoban DJ, Antimicrob Agents Chemother 2000 44 4 1089 1092 10.1128/AAC.44.4.1089-1092.2000 10722520 (Pubitemid 30165299)
16. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh. Akram M, Shahid M, Khan AU, India Ann Clin Microbiol Antimicrob 2007 6 4 10.1186/1476-0711-6-4 (Pubitemid 46605897)
17. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, et al. Antimicrob Agents Chemother 2008 52 4 1430 1437 10.1128/AAC.01538-07 18285482 (Pubitemid 351522009)
18. Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study. Aypak C, Altunsoy A, Duzgun N, Ann Clin Microbiol Antimicrob 2009 8 27 10.1186/1476-0711-8-27 19852849
19. Extended-spectrum beta-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Meier S, Weber R, Zbinden R, Ruef C, Hasse B, Infection 2011 39 4 333 340 10.1007/s15010-011-0132-6 21706226
20. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Bean DC, Krahe D, Wareham DW, Ann Clin Microbiol Antimicrob 2008 7 13 10.1186/1476-0711-7-13 18564430 (Pubitemid 351935849)
21. Resistance of uropathogens in symptomatic urinary tract infections in Leon, Nicaragua. Matute AJ, Hak E, Schurink CA, McArthur A, Alonso E, Paniagua M, Van Asbeck E, Roskott AM, Froeling F, Rozenberg-Arska M, et al. Int J Antimicrob Agents 2004 23 5 506 509 10.1016/j.ijantimicag.2003.10.003 15120732 (Pubitemid 38569602)
22. Prevalence and risk factors for multidrug resistant uropathogens in ED patients. Wright SW, Wrenn KD, Haynes M, Haas DW, Am J Emerg Med 2000 18 2 143 146 10.1016/S0735-6757(00)90005-6 10750917 (Pubitemid 30163886)
23. Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines. Muvunyi CM, Masaisa F, Bayingana C, Mutesa L, Musemakweri A, Muhirwa G, Claeys GW, AmJTrop Med Hyg 2011 84 6 923 928
24. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Pitout JD, Laupland KB, Lancet Infect Dis 2008 8 3 159 166 10.1016/S1473-3099(08)70041-0 18291338 (Pubitemid 351249250)
25. Causative agents of urinary tract infections in children and their antibiotic sensitivity pattern: a hospital based study. Rai GK, Upreti HC, Rai SK, Shah KP, Shrestha RM, Nepal Med Coll J 2008 10 2 86 90 18828428
26. Uropathogens and their antimicrobial susceptibility pattern in Bharatpur, Nepal. Acharya A, Gautam R, Subedee L, Nepal Med Coll J 2011 13 1 30 33 21991698
27. Antibiogram pattern of isolates from UTI cases in Eastern part of Nepal. Kumari N, Ghimire G, Magar JK, Mohapatra TM, Rai A, Nepal Med Coll J 2005 7 2 116 118 16519077
28. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use Country. Christiansen N, Nielsen L, Jakobsen L, Stegger M, Hansen LH, Frimodt-Moller N, Microb Drug Resist 2011 17 3 395 406 10.1089/mdr.2011.0015 21668371
29. Analysis of the plasmids of Escherichia coli O148:H28 from travellers with diarrhea. Danbara H, Komase K, Kirii Y, Shinohara M, Arita H, Makino S, Yoshikawa M, Microb Pathog 1987 3 4 269 278 10.1016/0882-4010(87)90060-X 3332908
30. Molecular characterization of extended-spectrum beta-lactamases in Enterobacteriaceae from patients of two hospitals in Saxony, Germany. Schmitt J, Jacobs E, Schmidt H, J Med Microbiol 2007 56 Pt 2 241 249 17244807
31. Characterization of drug resistant Salmonella enterica serotype Typhimurium by antibiograms, plasmids, integrons, resistance genes and PFGE. Benacer D, Thong KL, Watanabe H, Puthucheary SD, J Microbiol Biotechnol 2010 20 6 1042 1052 10.4014/jmb.0910.10028 20622506
32. The worldwide emergence of plasmid-mediated quinolone resistance. Robicsek A, Jacoby GA, Hooper DC, Lancet Infect Dis 2006 6 10 629 640 10.1016/S1473-3099(06)70599-0 17008172 (Pubitemid 44427732)
33. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Bennett PM, Br J Pharmacol 2008 153 Suppl 1 347 S357 18193080
34. Occurrence of multiple antibiotic resistance and R plasmids in Enterobacteriaceae isolated from children in the Sudan. Shears P, Suliman G, Hart CA, Epidemiol Infect 1988 100 1 73 81 10.1017/S0950268800065572 3338507 (Pubitemid 18057983)
35. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea. Shin JH, Jung HJ, Lee JY, Kim HR, Lee JN, Chang CL, Microb Drug Resist 2008 14 3 221 226 10.1089/mdr.2008.0834 18707554
36. High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China. Yang H, Chen H, Yang Q, Chen M, Wang H, Antimicrob Agents Chemother 2008 52 12 4268 4273 10.1128/AAC.00830-08 18809939
37. High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria. Ogbolu DO, Daini OA, Ogunledun A, Alli AO, Webber MA, Int J Antimicrob Agents 2011 37 1 62 66 10.1016/j.ijantimicag.2010.08.019 21074376